254 related articles for article (PubMed ID: 33585274)
1. Frequent Pet Contact as Risk Factor for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis.
Grehn C; Eschenhagen P; Temming S; Düesberg U; Neumann K; Schwarz C
Front Cell Infect Microbiol; 2020; 10():601821. PubMed ID: 33585274
[No Abstract] [Full Text] [Related]
2. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
3. IgE antibody to Aspergillus fumigatus recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis.
Knutsen AP; Hutcheson PS; Slavin RG; Kurup VP
Allergy; 2004 Feb; 59(2):198-203. PubMed ID: 14763934
[TBL] [Abstract][Full Text] [Related]
4. Disseminated aspergillosis in a patient with cystic fibrosis and allergic bronchopulmonary aspergillosis.
Chung Y; Kraut JR; Stone AM; Valaitis J
Pediatr Pulmonol; 1994 Feb; 17(2):131-4. PubMed ID: 8165040
[TBL] [Abstract][Full Text] [Related]
5. Serum anti-Aspergillus fumigatus antibodies by immunoblot and ELISA in cystic fibrosis with allergic bronchopulmonary aspergillosis.
Knutsen AP; Mueller KR; Hutcheson PS; Slavin RG
J Allergy Clin Immunol; 1994 May; 93(5):926-31. PubMed ID: 8182235
[TBL] [Abstract][Full Text] [Related]
6. Frequencies of pathogenic CFTR variants in Greek cystic fibrosis patients with allergic bronchopulmonary aspergillosis and Aspergillus fumigatus chronic colonization: A retrospective cohort study.
Noni M; Katelari A; Poulou M; Ioannidis D; Kapasouri EM; Tzetis M; Doudounakis SE; Kanaka-Gantenbein C; Spoulou V
J Mycol Med; 2023 Mar; 33(1):101326. PubMed ID: 36272381
[TBL] [Abstract][Full Text] [Related]
7. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis.
Mastella G; Rainisio M; Harms HK; Hodson ME; Koch C; Navarro J; Strandvik B; McKenzie SG
Eur Respir J; 2000 Sep; 16(3):464-71. PubMed ID: 11028661
[TBL] [Abstract][Full Text] [Related]
8. Allergic bronchopulmonary aspergillosis is associated with pet ownership in cystic fibrosis.
Thronicke A; Heger N; Antweiler E; Krannich A; Roehmel J; Brandt C; Staab D; Tintelnot K; Schwarz C
Pediatr Allergy Immunol; 2016 Sep; 27(6):597-603. PubMed ID: 27145047
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis.
Becker JW; Burke W; McDonald G; Greenberger PA; Henderson WR; Aitken ML
Chest; 1996 Jun; 109(6):1536-40. PubMed ID: 8769507
[TBL] [Abstract][Full Text] [Related]
10. Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy.
Hemmann S; Nikolaizik WH; Schöni MH; Blaser K; Crameri R
Eur J Immunol; 1998 Apr; 28(4):1155-60. PubMed ID: 9565354
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis.
Skov M; Koch C; Reimert CM; Poulsen LK
Allergy; 2000 Jan; 55(1):50-8. PubMed ID: 10696856
[TBL] [Abstract][Full Text] [Related]
12. Increasing Total Serum IgE, Allergic Bronchopulmonary Aspergillosis, and Lung Function in Cystic Fibrosis.
Gothe F; Kappler M; Griese M
J Allergy Clin Immunol Pract; 2017; 5(6):1591-1598.e6. PubMed ID: 28526275
[TBL] [Abstract][Full Text] [Related]
13. Prospective Evaluation of
Eschenhagen P; Grehn C; Schwarz C
Front Cell Infect Microbiol; 2020; 10():602836. PubMed ID: 33553006
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy.
Skov M; McKay K; Koch C; Cooper PJ
Respir Med; 2005 Jul; 99(7):887-93. PubMed ID: 15939251
[TBL] [Abstract][Full Text] [Related]
15. Immune responses to Aspergillus fumigatus and Pseudomonas aeruginosa antigens in cystic fibrosis and allergic bronchopulmonary aspergillosis.
Murali PS; Pathial K; Saff RH; Splaingard ML; Atluru D; Kurup VP; Fink JN
Chest; 1994 Aug; 106(2):513-9. PubMed ID: 7774329
[TBL] [Abstract][Full Text] [Related]
16. Allergic bronchopulmonary mycosis complicating cystic fibrosis.
Knutsen A; Slavin RG
Semin Respir Infect; 1992 Sep; 7(3):179-92. PubMed ID: 1475542
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis.
Ritz N; Ammann RA; Casaulta Aebischer C; Schoeni-Affolter F; Schoeni MH
Eur J Pediatr; 2005 Sep; 164(9):577-82. PubMed ID: 15926067
[TBL] [Abstract][Full Text] [Related]
18. Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis.
Gernez Y; Waters J; Mirković B; Lavelle GM; Dunn CE; Davies ZA; Everson C; Tirouvanziam R; Silver E; Wallenstein S; Chotirmall SH; McElvaney NG; Herzenberg LA; Moss RB
Eur Respir J; 2016 Jan; 47(1):177-85. PubMed ID: 26585435
[TBL] [Abstract][Full Text] [Related]
19. Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.
Perisson C; Destruys L; Grenet D; Bassinet L; Derelle J; Sermet-Gaudelus I; Thumerelle C; Prevotat A; Rosner V; Clement A; Corvol H
Respir Med; 2017 Dec; 133():12-15. PubMed ID: 29173443
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of mold exposure in cystic fibrosis patients' dwellings and allergic bronchopulmonary risk.
Rocchi S; Richaud-Thiriez B; Barrera C; Grenouillet F; Dalphin JC; Millon L; Reboux G
J Cyst Fibros; 2015 Mar; 14(2):242-7. PubMed ID: 25612900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]